Published in Front Immunol on May 19, 2017
Integrative genomics viewer. Nat Biotechnol (2011) 42.83
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science (2002) 12.75
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
Human diversity in killer cell inhibitory receptor genes. Immunity (1997) 4.82
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood (2008) 2.71
Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet (2007) 2.36
HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A (2008) 2.31
Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol (2007) 2.28
KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol (2005) 2.07
Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol (2001) 2.02
Genetic control of human NK cell repertoire. J Immunol (2002) 2.01
Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol (2007) 1.94
HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation. Blood (2014) 1.63
Genetic and functional relationships between MHC and NK receptor genes. Immunity (2001) 1.61
Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum Mol Genet (2009) 1.21
Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Réunion. Tissue Antigens (2005) 1.20
NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol (2012) 1.18
Relapse after allogeneic stem cell transplantation. Expert Rev Hematol (2010) 1.14
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? J Immunol (2008) 1.13
Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2009) 1.12
Variable NK cell receptors exemplified by human KIR3DL1/S1. J Immunol (2011) 1.12
Linkage disequilibrium organization of the human KIR superlocus: implications for KIR data analyses. Immunogenetics (2010) 1.12
The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood (2013) 1.10
Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens (2000) 1.03
Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals. PLoS One (2012) 1.02
Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology (2009) 1.01
Influence of KIR gene copy number on natural killer cell education. Blood (2013) 1.00
Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells. J Immunol (2009) 0.93
The role of KIR genes and ligands in leukemia surveillance. Front Immunol (2013) 0.91
Next generation sequencing: new tools in immunology and hematology. Blood Res (2013) 0.88
Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population. Eur J Immunol (2013) 0.87
Investigation of killer cell immunoglobulin-like receptor gene diversity, KIR2DL1 and KIR2DS1. Tissue Antigens (2008) 0.87
Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum Immunol (2004) 0.87
Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing. Am J Hum Genet (2016) 0.87
HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation. Front Immunol (2014) 0.87
Exome capture from saliva produces high quality genomic and metagenomic data. BMC Genomics (2014) 0.86
Alleles and intron polymorphism of KIR3DL1 shown by combination of allele group-specific primers and sequencing. Tissue Antigens (2008) 0.86
KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV. J Immunol (2016) 0.85
Amplified NKG2C+ NK cells in cytomegalovirus (CMV) infection preferentially express killer cell Ig-like receptor 2DL: functional impact in controlling CMV-infected dendritic cells. J Immunol (2013) 0.85
Investigation of killer cell immunoglobulin-like receptor gene diversity: II. KIR2DS4. Hum Immunol (2004) 0.84
Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med (2016) 0.83
Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol (2016) 0.83
Molecular determinant-based typing of KIR alleles and KIR ligands. Clin Immunol (2011) 0.83
A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples. BMC Genomics (2014) 0.82
Determining performance characteristics of an NGS-based HLA typing method for clinical applications. HLA (2016) 0.82
Investigation of killer cell immunoglobulinlike receptor gene diversity: I. KIR2DL4. Hum Immunol (2004) 0.81
Killer cell immunoglobulin-like receptor allele discrimination by high-resolution melting. Hum Immunol (2009) 0.81
New insights on the natural killer cell repertoire from a thorough analysis of cord blood cells. J Leukoc Biol (2016) 0.81
Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5. Tissue Antigens (2008) 0.81
Reproduction, infection and killer-cell immunoglobulin-like receptor haplotype evolution. Immunogenetics (2016) 0.80
KIR3DS1-Specific D0 Domain Polymorphisms Disrupt KIR3DL1 Surface Expression and HLA Binding. J Immunol (2015) 0.80
Extensive variation in gene copy number at the killer immunoglobulin-like receptor locus in humans. PLoS One (2013) 0.80
Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing. Methods Mol Biol (2012) 0.80
Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3. Tissue Antigens (2004) 0.79
The elucidation of KIR2DL4 gene polymorphism. Mol Immunol (2007) 0.79
Investigation of killer cell immunoglobulin-like receptor KIR2DL4 diversity by sequence-based typing in Chinese population. Tissue Antigens (2006) 0.79
Deciphering the KIR system at super-resolution for NK and T cell biology. Immunology (2016) 0.79
Class I HLA haplotypes form two schools that educate NK cells in different ways. Sci Immunol (2016) 0.79
Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1. Eur J Immunol (2016) 0.78
Use of killer cell immunoglobulin-like receptor genes as early markers of hematopoietic chimerism after double-umbilical cord blood transplantation. Haematologica (2015) 0.78
Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments. Front Immunol (2016) 0.78
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol (2016) 0.78
HLA-C levels impact natural killer cell subset distribution and function. Hum Immunol (2016) 0.78
Investigation of killer cell immunoglobulin-like receptor gene diversity V. KIR3DL2. Tissue Antigens (2004) 0.77
5' and 3' untranslated regions contribute to the differential expression of specific HLA-A alleles. Eur J Immunol (2015) 0.77
How important is NK alloreactivity and KIR in allogeneic transplantation? Best Pract Res Clin Haematol (2016) 0.77
Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations. Tissue Antigens (2007) 0.76
Impact of Graft-versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation. Transplantation (2016) 0.76
KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles. Sci Rep (2016) 0.75